CRT House of Representatives Sign-On Letter- The 21st Century Cures Act (Cures) is legislation passed in 2016 that included limits on the federal Medicaid Durable Medical Equipment (DME) subsidy to states in specific situations. This limitation, when applicable, involves applying Competitive Bid payment rates to certain DME items. The Cures Act was not meant to negatively impact CRT items, but unfortunately that is happening in some states. To formally inform CMS that Congress did not intend for the provision and DME Competitive Bid payment rates to be applied to CRT items, Representatives Bill Johnson (R-OH) and Robert Latta (R-OH) are sending a letter to CMS Administrator Verma. To strengthen the message, they are asking their fellow Representatives to add their signatures (sign-on) to the letter.
Follow this link to the .pdf that contains the letter:
For more details: